Integrating biology into civil engineering, biogenic construction promotes sustainable practices that address environmental ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

Researchers engineered Shewanella oneidensis to produce extracellular DNA hydrogels, enabling the development of biohybrid materials for use in energy, biotechnology, and regenerative systems.

Biosensors are changing how we monitor health, but rapid innovation raises tough questions around privacy, regulation, and ...

Dozens of problematic papers remain in the literature, after a publication hit by fraudsters pledged to tackle the issue.

Skin microbes do more than coexist—they shape immune responses, repair tissue, and influence gene expression across your ...

Expanded leadership team as eXoZymes ramps up commercial growthDamien Perriman brings more than two decades of experience in successfully ...

Those natural essential oils you love in your skincare? More than 90% of a plant is typically discarded during the oil ...

A Portuguese study found that over half of paracetamol-based painkillers and a quarter of ibuprofen liquids contain gluten or ...

PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs ...

Several studies have reported that the coronavirus disease 2019 (COVID-19) can lead to heart rate variability (HRV), with the ...